Are Pharma Marketers Fighting the Last War?

In this ISSUE

Regenerative Medicine Companies Successfully Advance Stem Cell Therapies

Ketamine-Like Compound Offers New Hope as a Potential Antidepressant and Non-Opioid Painkiller

Cystic Fibrosis: The Importance of Patient Advocacy

Top Story

FDA Only Winner as New Budget Battle Begins

The FDA planned budget features added funds allotted to improved oversight of drugs, biologics, and medical devices, writes Jill Wechsler
… /Read more/

Patient Adherence: A Hard Pill to Swallow?
Asia-Pacific: Thursday, April 11, 2019 at 11:30am IST | 2pm CST | 3pm JST
North America: Thursday, April 11, 2019 at 1pm EDT | 12pm CDT | 10am PDT

Strategy

Is There Evidence in Real-World Evidence?

The discrepancies between trial and real-life patient conditions are such that Real-World Evidence (RWE) can be utilized to supplement this process, writes Partha S. Anbil
… /Read more/

Technology

How Blockchain Can Support FDA's New Agenda

The digitization of healthcare is paving the way to accelerate drug development in the industry, and the FDA is doing its best to support industry, writes Alexis Normand
… /Read more/

Using Real-World Evidence for U.S. Regulatory Decision-Making: What Pharma Needs to Know
On Demand

Learn More

Patients

Patient Advocacy: The Pharma Perspective

Perspectives from big pharma and the rare disease space on how patient advocacy is evolving as a corporate function
… /Read More/

Japan Market Entry: How to Navigate the Clinical Development Regulatory Environment and Best Methods to Utilize Opportunities
On Demand

Learn More

Calendar

/ March 27–28: 12^th Annual Expanded Access Programs /

Philadelphia, PA

/ April 16–18, 2019: PCC 2019—CBI's 16^th Annual Pharmaceutical Compliance Congress /

Washington, DC

/ May 15: MDR Workshop: Transitioning to the EU MDR and Managing Legacy Devices /

Brussels, Belgium

/ May 20–22: 21^st Medicaid and Government Pricing Congress /

Orlando, FL

/ June 3–6: BIO International Convention /

Philadelphia, PA

/ June 12–13: Rare Disease Innovation and Partnering Summit /

Boston, MA

The Pharm Exec Podcast: Sensitive Topics in Pharma

The Pharm Exec editors talk with Seth Lederman, co-founder, CEO and chairman of Tonix Pharmaceuticals about how to navigate creating drugs for conditions such as PTSD and AIDS, running a business, and academia
… /Click here to listen/

Industry update

//Pfenex (San Diego, CA) appointed Martin B. Brenner, DVM, Ph.D., as its Chief Scientific Officer. // Gritstone Oncology (Emeryville, CA) announced that Mike Forcht, Ed.D., M.B.A., joined the company as Senior Vice President of Human Resources. // La Jolla Pharmaceutical Company (Sam Diego, CA) appointed Darryl Wellinghoff as Chief Commercial Officer. // Motif Bio (New York, NY) announced that Richard C. E. Morgan resigned as Non-executive Chairman. Bruce Williams, a long-standing Board member, was appointed Interim Chairman. // Sanofi (Paris, France) appointed Ameet Nathwani, M.D., as Chief Digital Officer

advertise with us / print subscribe / digital subscribe / visit pharmexec.com